We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$39.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.48B
Cap. Flow %
6.28%
Top 10 Hldgs %
5.86%
Holding
3,447
New
176
Increased
1,376
Reduced
1,602
Closed
253

Sector Composition

Rank Sector Weight
1 Financials 10.78%
2 Consumer Discretionary 10.44%
3 Technology 10.24%
4 Industrials 10.05%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTM
3126
DELISTED
U.S. Geothermal Inc.
HTM
$30K ﹤0.01%
8,458
-845
-9% -$3.5K
EDMC
3127
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
$30K ﹤0.01%
17,836
+6,576
+58% +$17.7K
FBIO icon
3128
Fortress Biotech
FBIO
$104M
$29K ﹤0.01%
1,107
-440
-28% -$11.6K
MVIS icon
3129
Microvision
MVIS
$6.21M
$29K ﹤0.01%
14,226
-1,422
-9% -$2.59K
HTCH
3130
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$29K ﹤0.01%
11,552
-6,906
-37% -$16.3K
ETRM
3131
DELISTED
EnteroMedics Inc.
ETRM
$29K ﹤0.01%
17
-2
-11% -$3.74K
AVNW icon
3132
Aviat Networks
AVNW
$265M
$28K ﹤0.01%
3,642
-1,952
-35% -$15K
DSS icon
3133
DSS Inc
DSS
$5.39M
$28K ﹤0.01%
9
+1
+13% +$2.94K
INSG icon
3134
Inseego
INSG
$114M
$28K ﹤0.01%
1,453
-145
-9% -$2.63K
QMCO icon
3135
Quantum Corp
QMCO
$419M
$28K ﹤0.01%
141
-5
-3% -$914
SVRA icon
3136
Savara
SVRA
$1.12B
$28K ﹤0.01%
637
-64
-9% -$2.79K
ATRS
3137
DELISTED
Antares Pharma, Inc.
ATRS
$28K ﹤0.01%
+10,492
New +$31.6K
RIOT icon
3138
Riot Platforms
RIOT
$7.63B
$26K ﹤0.01%
1,438
-144
-9% -$2.47K
LOCM
3139
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$26K ﹤0.01%
12,662
-1,266
-9% -$2.36K
GNVC
3140
DELISTED
GenVec, Inc.
GNVC
$26K ﹤0.01%
1,027
-102
-9% -$2.5K
GEG icon
3141
Great Elm Group
GEG
$67.4M
$25K ﹤0.01%
939
-365
-28% -$9.37K
TOVX icon
3142
Theriva Biologics
TOVX
$9.64M
$25K ﹤0.01%
2
UAMY icon
3143
United States Antimony
UAMY
$751M
$25K ﹤0.01%
17,806
-1,780
-9% -$3.24K
SES
3144
DELISTED
Synthesis Energy Systems Inc.
SES
$25K ﹤0.01%
206
-21
-9% -$2.27K
IMUC
3145
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$25K ﹤0.01%
569
-57
-9% -$2.75K
AIM
3146
AIM ImmunoTech
AIM
$7.03M
$25K ﹤0.01%
2
NAVB
3147
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$24K ﹤0.01%
823
+168
+26% +$5.43K
GV
3148
DELISTED
Goldfield Corporation
GV
$23K ﹤0.01%
13,328
-1,332
-9% -$2.58K
REE
3149
DELISTED
RARE ELEMENT RES LTD
REE
$23K ﹤0.01%
17,604
-1,760
-9% -$2.3K
ROX
3150
DELISTED
Castle Brands, Inc.
ROX
$22K ﹤0.01%
24,810
-2,480
-9% -$2.44K

Similar funds

Guggenheim Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Guggenheim Capital held 3,447 positions worth $39.5B, up 12% from $35.2B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Guggenheim Capital deployed $2.48B of net new capital in Q2 2014, opening 176 new positions and adding to 1,376 existing holdings. Its largest new stake was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $95.8M trimmed.

  • Guggenheim Capital's largest Q2 2014 buy was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.
  • Guggenheim Capital added most to Stanley Black & Decker in Q2 2014, an estimated $62.1M increase.
  • Guggenheim Capital's biggest Q2 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $95.8M.
  • Guggenheim Capital fully exited LSI CORPORATION in Q2 2014, selling an estimated $44.6M.
  • Guggenheim Capital's ten largest holdings make up 5.9% of its $39.5B portfolio in Q2 2014.
  • Guggenheim Capital opened 176 new positions and closed 253 in Q2 2014.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $39.5B.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.